In focus
Latest feed
Palatin's Latest Quarter: Vyleesi Surges, Key Drug Trials Advance, and a Glimpse into the Future
Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet
Veradermics Steps Onto the Public Stage: A Deep Dive into Their $200 Million IPO Bet
A Beacon of Hope: BPGbio's BPM31510 Earns FDA Orphan Drug Status for Primary CoQ10 Deficiency
Latest headlines
